SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...
On Nov 8, Japanese drugmaker Takeda Pharmaceutical Co Ltd launched a partnership with OrigiMed to promote the R&D and ...
Medical Device Network on MSN
SPT Labtech and Alithea Genomics partner on single-cell transcriptomics
SPT Labtech and Swiss company Alithea Genomics have announced a partnership for automating single-cell transcriptomic ...
The illustration of protein structure (domains) on the left side, and corresponding exons in the FLT3 gene are displayed on the right side. FMS-like tyrosine kinase 3 (FLT3) mutations represent some ...
Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.
The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, ...
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback